Press release from Business Wire
Incyte to Present at the Canaccord Genuity 33rd Annual Growth Conference
Monday, August 05, 2013
Incyte to Present at the Canaccord Genuity 33rd Annual Growth Conference08:00 EDT Monday, August 05, 2013
WILMINGTON, Del. (Business Wire) -- Incyte Corporation (Nasdaq:INCY) announced today it will present at the Canaccord Genuity 33rd Annual Growth Conference on Wednesday, August 14 at 10:30 a.m. (EDT) in Boston.
The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications